Improving symptom burden and quality of life in patients with myelofibrosis: current strategies and future directions-Reference-Cited by-同舟云学术

Improving symptom burden and quality of life in patients with myelofibrosis: current strategies and future directions

Published:2021-07-03 Issue:7 Volume:14 Page:607-619
ISSN:1747-4086
Container-title:Expert Review of Hematology
language:en
Short-container-title:Expert Review of Hematology

Author:

Yoon James¹,Pettit Kristen¹

Affiliation:

1. Department of Medicine, Division of Hematology/Oncology, Michigan Medicine and University of Michigan Medical School, Ann Arbor, Michigan, United States

Publisher

Informa UK Limited

Subject

Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474086.2021.1944096

Reference83 articles.

1. Molecular aspects of myeloproliferative neoplasms

2. Mutations and prognosis in primary myelofibrosis

3. SRSF2 mutations in primary myelofibrosis: significant clustering with IDH mutations and independent association with inferior overall and leukemia-free survival

4. Disordered Epigenetic Regulation in the Pathophysiology of Myeloproliferative Neoplasms

5. Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Applying enhanced recovery after surgery protocols in a patient with a giant spleen: a case report;Frontiers in Oncology;2024-08-15

2. Translation, Cultural Adaptation, and Validation into Romanian of the Myeloproliferative Neoplasm Symptom Assessment Form—Total Symptom Score (MPN-SAF TSS or MPN-10) Questionnaire;Journal of Clinical Medicine;2024-06-02

3. Androgen use in bone marrow failures and myeloid neoplasms: Mechanisms of action and a systematic review of clinical data;Blood Reviews;2023-11

4. Effect of hypoxia on HIF-1α and NOS3 expressions in CD34+ cells of JAK2V617F-positive myeloproliferative neoplasms;Advances in Medical Sciences;2023-09

5. Quality of life and affecting factors in myelofibrosis patients;2023-08-31